Hugh M. Clink

583 total citations
23 papers, 441 citations indexed

About

Hugh M. Clink is a scholar working on Hematology, Oncology and Infectious Diseases. According to data from OpenAlex, Hugh M. Clink has authored 23 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in Hugh M. Clink's work include Acute Myeloid Leukemia Research (4 papers), Antifungal resistance and susceptibility (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Hugh M. Clink is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Antifungal resistance and susceptibility (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Hugh M. Clink collaborates with scholars based in Saudi Arabia, United Kingdom and Sweden. Hugh M. Clink's co-authors include T J McElwain, Michael Ellis, P Ernst, David J. Spence, I. E. Smith, Margaret MacGillivray, Sheila Sherlock, Michael Gerken, David J. Clain and Peter Ernst and has published in prestigious journals such as The Lancet, Cancer and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Hugh M. Clink

22 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugh M. Clink Saudi Arabia 12 148 147 144 106 65 23 441
Laura Marbello Italy 10 125 0.8× 84 0.6× 143 1.0× 105 1.0× 28 0.4× 20 388
Dean Buckner United States 9 59 0.4× 165 1.1× 77 0.5× 211 2.0× 19 0.3× 14 458
R Duquesnoy United States 16 82 0.6× 98 0.7× 103 0.7× 117 1.1× 112 1.7× 41 832
Katjana Orlopp Germany 10 122 0.8× 245 1.7× 149 1.0× 166 1.6× 144 2.2× 17 567
M. Essink Germany 8 82 0.6× 89 0.6× 87 0.6× 40 0.4× 65 1.0× 11 320
Øystein Wendelbo Norway 12 70 0.5× 93 0.6× 123 0.9× 93 0.9× 52 0.8× 37 409
Michele W. Sugrue United States 14 167 1.1× 135 0.9× 154 1.1× 320 3.0× 46 0.7× 27 668
P. Fixe France 10 40 0.3× 73 0.5× 78 0.5× 163 1.5× 85 1.3× 12 419
Douglas P. Rhone United States 14 39 0.3× 71 0.5× 85 0.6× 55 0.5× 76 1.2× 25 441
K. Ramachandran India 14 116 0.8× 75 0.5× 71 0.5× 48 0.5× 90 1.4× 70 550

Countries citing papers authored by Hugh M. Clink

Since Specialization
Citations

This map shows the geographic impact of Hugh M. Clink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh M. Clink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh M. Clink more than expected).

Fields of papers citing papers by Hugh M. Clink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh M. Clink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh M. Clink. The network helps show where Hugh M. Clink may publish in the future.

Co-authorship network of co-authors of Hugh M. Clink

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh M. Clink. A scholar is included among the top collaborators of Hugh M. Clink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh M. Clink. Hugh M. Clink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solh, Hassan El, Andrew Padmos, Kwesi Sackey, et al.. (1997). Bone Marrow Transplantation in Patients with Fanconi Anemia: Experience with Cyclophosphamide and Total Body Irradiation Conditioning Regimen. Pediatric Hematology and Oncology. 14(1). 67–72.
2.
Solh, Hassan El, Krishna Rao, Andrew Padmos, et al.. (1997). Engraftment Failure Following Bone Marrow Transplantation in Children with Thalassemia Major Using Busulfan and Cyclophosphamide Conditioning. Pediatric Hematology and Oncology. 14(1). 73–77. 4 indexed citations
3.
Solh, Hassan El, Neelam Giri, Andrew Padmos, et al.. (1995). Bone Marrow Transplantation for Infantile Malignant Osteopetrosis. Journal of Pediatric Hematology/Oncology. 17(4). 350–355. 26 indexed citations
4.
Clink, Hugh M., et al.. (1995). Evans Syndrome Associated with Venous Thrombosis. Annals of Saudi Medicine. 15(2). 168–170. 3 indexed citations
5.
Ellis, Michael, Hugh M. Clink, P Ernst, et al.. (1994). Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases. 13(1). 3–11. 83 indexed citations
6.
Ellis, Michael, Hugh M. Clink, D. Younge, & Bo Hainau. (1994). Successful Combined Surgical and Medical Treatment of Fusarium Infection after Bone Marrow Transplantation. Scandinavian Journal of Infectious Diseases. 26(2). 225–228. 18 indexed citations
7.
Ellis, M., S. M. Hussain Qadri, David J. Spence, et al.. (1994). The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures. Journal of Antimicrobial Chemotherapy. 33(6). 1223–1228. 23 indexed citations
8.
McLean, Donald R., Hugh M. Clink, Peter Ernst, et al.. (1994). Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes. Cancer. 73(12). 3037–3040. 29 indexed citations
9.
Ellis, Michael, et al.. (1992). Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B. Antimicrobial Agents and Chemotherapy. 36(1). 172–179. 49 indexed citations
10.
Roberts, George T., et al.. (1992). Morphologic immunophenotypic and cytogenetic patterns of adult acute myeloid leukemia in Saudi Arabia. Leukemia Research. 16(2). 181–190. 9 indexed citations
11.
Ernst, Peter, et al.. (1991). Multiple Myeloma: A Review of 92 Cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Annals of Saudi Medicine. 11(6). 642–646. 6 indexed citations
12.
Lawler, Sylvia D., Brenda Summersgill, Hugh M. Clink, & T J McElwain. (1980). Cytogenetic Follow‐up Study of Acute Non‐lymphocytic Leukaemia. British Journal of Haematology. 44(3). 395–405. 23 indexed citations
13.
Smith, I. E., R Powles, Hugh M. Clink, et al.. (1977). Early deaths in acute myelogenous leukemia. Cancer. 39(4). 1710–1714. 18 indexed citations
14.
Atkinson, K, Hugh M. Clink, S. D. Lawler, et al.. (1977). Encephalopathy following bone marrow transplantation. European Journal of Cancer (1965). 13(6). 623–625. 11 indexed citations
15.
Smith, I. E., Hugh M. Clink, Michael Gerken, & T J McElwain. (1976). VP 16-213 in acute myelogenous leukaemia. Postgraduate Medical Journal. 52(604). 66–70. 47 indexed citations
16.
Clink, Hugh M.. (1974). Blood Disorders due to Drugs and Other Agents. Journal of Clinical Pathology. 27(1). 86.1–86. 19 indexed citations
17.
Clink, Hugh M., T. R. E. Pilkington, W.B. Robertson, B.F. Robinson, & N. J. Woolf. (1969). PAY SCALES FOR CLINICAL TEACHERS. The Lancet. 293(7589). 306–307. 1 indexed citations
18.
Clain, David J., et al.. (1967). HEPATIC COMA DUE TO ACUTE HEPATIC NECROSIS TREATED BY EXCHANGE BLOOD-TRANSFUSION. The Lancet. 290(7508). 169–172. 58 indexed citations
19.
Clink, Hugh M. & Gersende Caron. (1966). Pseudo‐adenomatous squamous carcinoma of the skin. The Journal of Pathology and Bacteriology. 91(2). 597–598. 1 indexed citations
20.
Clink, Hugh M.. (1963). Foetal Death after Promazine and Pethidine. BMJ. 2(5358). 684.2–684. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026